CD44 is a complex transmembrane-binding glycoprotein [53,54], which can be involved in the regulation of many important signaling pathways such as tumor proliferation, invasion, metastasis, and treatment resistance, and was related to the adverse prognosis of patients [52,53]. The gene discussed is CD44; the disease is neoplasm.